Oculus Innovative Sciences Announces Introduction of Alevicyn SG Antipruritic Spray Gel for Relief of Pain and Itch in Atopic Dermatitis Aug 19, 2015
Oculus Innovative Sciences Reports Financial Results for the First Quarter of Fiscal Year 2016 Jul 30, 2015
Oculus Innovative Sciences Announces Fiscal First Quarter 2016 Financial Results and Conference Call Jul 16, 2015
Oculus Innovative Sciences Receives New U.S. Patent for Microcyn(R) Technology in Treatment of Atopic Dermatitis Jul 8, 2015
Oculus Innovative Sciences Announces Sale of 1.65 Million Shares of Ruthigen Stock for $4.5 Million in Non-Dilutive Funding Jun 16, 2015
Oculus Innovative Sciences Reports Financial Results for the Fourth Quarter of Fiscal Year 2015 Jun 11, 2015
Oculus Innovative Sciences Receives FDA Clearance for Novel Atopic Dermatitis Dermatology Product Jun 8, 2015
Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2015 Financial Results and Conference Call May 28, 2015
Oculus Innovative Sciences Announces Launch of MicrocynAH(R) Farm and Ranch Animal Healthcare Products Apr 16, 2015
